SPDR S&P Pharmaceuticals ETF (XPH) Holdings $45.94 -0.11 (-0.24%) Closing price 04:10 PM EasternExtended Trading$45.94 +0.01 (+0.01%) As of 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Top 25 XPH HoldingsRankCompanyCurrent PriceWeightShares Held1TARSTarsus Pharmaceuticals$54.14-0.9%4.46%139,6962ELANElanco Animal Health$17.78+0.5%4.28%403,2213VTRSViatris$10.75+1.1%4.04%640,7504JNJJohnson & Johnson$177.40+0.7%3.82%37,0595RPRXRoyalty Pharma$36.19+0.8%3.62%168,9846JAZZJazz Pharmaceuticals$118.79+0.9%3.58%52,0737MRKMerck & Co., Inc.$85.48+1.5%3.50%71,6378PFEPfizer$25.41+1.4%3.48%235,0469CORTCorcept Therapeutics$71.51-0.3%3.43%80,76910AXSMAxsome Therapeutics$111.13+1.8%3.41%53,237 Get the Latest News and Ratings for XPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 11BMYBristol Myers Squibb$48.80+1.3%3.23%114,71212OGNOrganon & Co.$9.38+1.0%3.15%570,82713ZTSZoetis$154.43+1.4%3.12%34,59314ANIPANI Pharmaceuticals$89.690.0%2.94%55,45315LLYEli Lilly and Company$706.48+1.2%2.87%7,11516PRGOPerrigo$23.38+1.5%2.86%210,22717HRMYHarmony Biosciences$36.50+0.2%2.83%131,62318LQDALiquidia Technologies$27.68-0.1%2.71%176,13719XERSXeris Biopharma$7.48+1.6%2.70%627,11520PBHPrestige Consumer Healthcare$65.58+1.1%2.58%67,59921SUPNSupernus Pharmaceuticals$42.76-0.5%2.43%97,58222OCULOcular Therapeutix$12.16-1.3%2.42%324,71623PCRXPacira BioSciences$24.99+0.4%2.41%163,65824AMRXAmneal Pharmaceuticals$9.35+0.9%2.28%411,18025AMPHAmphastar Pharmaceuticals$30.25+1.6%2.24%125,701 Geographic ExposureUnited States91.6%Ireland6.4%Singapore1.9%Currency ExposureUSD99.9%Sector ExposureHealth Care96.7%Energy1.9%Industrials1.3%Industry ExposureBiotechnology57.4%Pharmaceuticals36.8%Health Care Equipment & Supplies2.4%Renewable Energy1.9%Commercial Services & Supplies1.3%SubIndustry ExposureBiotechnology45.5%Pharmaceuticals42.2%Health Care Supplies2.4%Renewable Energy Equipment1.9%Coupon Exposure4-60.1%Maturity Exposure5-100.1% Related Companies and Tools Related Companies SPDR S&P Health Care Equipment ETF Holdings Direxion Daily Healthcare Bull 3x Shares Holdings Invesco S&P SmallCap Health Care ETF Holdings Simplify Health Care ETF Holdings KraneShares MSCI All China Health Care Index ETF Holdings Invesco Dorsey Wright Healthcare Momentum ETF Holdings ALPS Medical Breakthroughs ETF Holdings Invesco Biotechnology & Genome ETF Holdings SPDR S&P Health Care Services ETF Holdings Simplify Propel Opportunities ETF Holdings This page (NYSEARCA:XPH) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access